158 related articles for article (PubMed ID: 30275188)
21. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.
Lee JS; Oh Y; Park JH; Kyung SY; Kim HS; Yoon S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430288
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs.
Choi AR; Kim JH; Cheon JH; Kim HS; Yoon S
Anticancer Res; 2016 Nov; 36(11):5859-5866. PubMed ID: 27793909
[TBL] [Abstract][Full Text] [Related]
23. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Kim JH; Choi AR; Kim YK; Yoon S
Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
[TBL] [Abstract][Full Text] [Related]
24. Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells.
Jiang C; Zheng T; Park JH; Lee JS; Oh Y; Kundu A; Kim HS; Yoon S
Anticancer Res; 2021 Dec; 41(12):6179-6190. PubMed ID: 34848472
[TBL] [Abstract][Full Text] [Related]
25. Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis
Kim KS; Jiang C; Kim JY; Park JH; Kim HR; Lee SH; Kim HS; Yoon S
Front Oncol; 2020; 10():696. PubMed ID: 32528877
[TBL] [Abstract][Full Text] [Related]
26. Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition.
Lim JS; Park Y; Lee BM; Kim HS; Yoon S
Anticancer Res; 2016 Oct; 36(10):5063-5070. PubMed ID: 27798865
[TBL] [Abstract][Full Text] [Related]
27. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
Lu ZN; Shi ZY; Dang YF; Cheng YN; Guan YH; Hao ZJ; Tian B; He HW; Guo XL
Biomed Pharmacother; 2019 Dec; 120():109478. PubMed ID: 31568987
[TBL] [Abstract][Full Text] [Related]
28. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
29. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
Yuan Z; Wang H; Hu Z; Huang Y; Yao F; Sun S; Wu B
Nutr Cancer; 2015; 67(1):126-36. PubMed ID: 25514492
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL
Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
[TBL] [Abstract][Full Text] [Related]
31. Hyperin Enhances the Sensitivity of HCT8/VCR Colon Cancer Cell Line to Vincristine by Down-Regulating P-Glycoprotein.
Wang LM; Zhang MY; Zhu QS; Lu CF; Bai X
Clin Lab; 2018 Mar; 64(3):269-275. PubMed ID: 29739100
[TBL] [Abstract][Full Text] [Related]
32. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas.
Uematsu T; Hasegawa T; Hiraoka BY; Komatsu F; Matsuura T; Yamada AS; Yamaoka M
Int J Cancer; 2001 Apr; 92(2):187-94. PubMed ID: 11291044
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
[TBL] [Abstract][Full Text] [Related]
35. SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition.
Kim JH; Chae M; Choi AR; Sik Kim H; Yoon S
Eur J Pharmacol; 2014 Jan; 723():141-7. PubMed ID: 24333214
[TBL] [Abstract][Full Text] [Related]
36. DHPAC, a novel synthetic microtubule destabilizing agent, possess high anti-tumor activity in vincristine-resistant oral epidermoid carcinoma in vitro and in vivo.
Zhang Y; Gong FL; Lu ZN; Wang HY; Cheng YN; Liu ZP; Yu LG; Zhang HH; Guo XL
Int J Biochem Cell Biol; 2017 Dec; 93():1-11. PubMed ID: 29074436
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.
Mumenthaler SM; Ng PY; Hodge A; Bearss D; Berk G; Kanekal S; Redkar S; Taverna P; Agus DB; Jain A
Mol Cancer Ther; 2009 Oct; 8(10):2882-93. PubMed ID: 19825806
[TBL] [Abstract][Full Text] [Related]
38. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
Cheng YH; Li LA; Lin P; Cheng LC; Hung CH; Chang NW; Lin C
Toxicol Appl Pharmacol; 2012 Sep; 263(3):360-7. PubMed ID: 22820424
[TBL] [Abstract][Full Text] [Related]
39. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
40. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway.
Lin FZ; Wang SC; Hsi YT; Lo YS; Lin CC; Chuang YC; Lin SH; Hsieh MJ; Chen MK
Phytomedicine; 2019 Feb; 54():1-8. PubMed ID: 30668359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
